Tak Wah Mak

Tak Wah Mak

Tak Wah Mak, is a Canadian medical researcher, geneticist, oncologist, and biochemist. He first became widely known for his discovery of the T-cell receptor in 1983 and pioneering work in the genetics of immunology. In 1995, Mak published a landmark paper on the discovery of the function of the immune checkpoint protein CTLA-4, thus opening the path for immunotherapy/checkpoint inhibitors as a means of cancer treatment. Mak is also the founder of Agios Pharmaceuticals, whose lead compound, IDHIFA®, was approved by the FDA for acute myeloid leukemia in August 2017, becoming the first drug specifically targeting cancer metabolism to be used for cancer treatment. He has worked in a variety of areas including biochemistry, immunology, and cancer genetics.

From *.wikipedia.org,
General Info
.
Male
Date of Birth
October 4th, 1946
Age
78
Birth Place
People's Republic of China, Guangdong
Star Sign
Libra
Social Networks , Links
Interest
Loading Chart...
Lists
    index: 1x 0.040502071380615s
fmsppl-page-output: 1x 0.036758899688721s
t_/pages/fms-person-json: 1x 0.036725997924805s
t_/blocks/person-card-json: 1x 0.023468017578125s
headline: 7x 0.014797925949097s
t_/common/header: 1x 0.012477159500122s
router_page: 1x 0.0029768943786621s
t_/common/head: 1x 0.0013642311096191s
head-facts: 1x 0.0013108253479004s
t_/common/footer: 1x 0.00056123733520508s
t_/common/searcher-result: 1x 1.6927719116211E-5s
----- END OF DUMP (2025-02-20 02:13:02)  -----